Johnson & Johnson unit Janssen Global Services said on Saturday that it does not intend to make an offer for biotech company Horizon Therapeutics Plc.
Last month, Horizon Therapeutics - which has a market capitalization of about $18 billion - said it was in talks with Amgen Inc, Sanofi and Janssen Global Services.
https://finance.yahoo.com/news/j-j-unit-says-does-223106419.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.